Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dexmedetomidine Ropivacaine Versus Plain Ropivacaine in Bilateral Pectoralis Nerve Block

NCT05897307 is registered in ClinicalTrials.gov with Fayoum University Hospital as lead sponsor.

NCT NCT05897307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05897307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dexmedetomidine Ropivacaine Versus Plain Ropivacaine in Bilateral Pectoralis Nerve Block
Lead sponsor
Fayoum University Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
August 1, 2023
Completion date
August 20, 2024
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post operative pain